Consensus guidelines for the treatment of Nephrotic Syndrome in Children of Pakistan

Endorsed by Pakistan Pediatric Association- Nephrology Group

Kirjoittajat

  • Ali Asghar A Lanewala Sindh Institute of Urology & Transplantation, Karachi
  • Seema Hashmi
  • veena Tresa Sindh Institute of Urology & Transplantation, Karachi
  • Sabeeta Khatri Sindh Institute of Urology & Transplantation, Karachi
  • Irshad Ali Bajeer Sindh Institute of Urology & Transplantation, Karachi
  • Afshan Ehsan Sindh Institute of Urology & Transplantation, Karachi
  • Khemchand N Moorani National Institute of Child Health (NICH) Jinnah Sindh Medical University (JSMU) Karachi
  • Sadaf Asim National Institute of Child Health (NICH) Jinnah Sindh Medical University (JSMU) Karachi
  • Bilquis Abro

DOI:

https://doi.org/10.53778/pjkd38101

Avainsanat:

pediatric, nephrotic syndrom, relapsing nephrotic syndrome, management, resistant nephrotic syndrome, rituximab, prednisolone, cyclosporine, tacrolimus, cyclophosphamide

Abstrakti

This guideline was prepared for the pediatric nephrologists and the genral pediatrician to review the subject and update with the treatment of different manifestaion of childhood nephrotic syndrome.

PJKD

Tiedostolataukset

Julkaistu

2021-02-07

Numero

Vol 3 Nro 8 (2019): Pakistan Journal of Kidney Diseases

Osasto

Supplement

Lisenssi

Copyright (c) 2021 Ali Asghar A Lanewala, Seema Hashmi, veena Tresa, Sabeeta Khatri, Irshad Ali Bajeer, Afshan Ehsan, Khemchand N Moorani, Sadaf Asim, Bilquis Abro

Creative Commons License

Tämä työ on lisensoitu Creative Commons Nimeä-EiKaupallinen 4.0 Kansainvälinen Julkinen -lisenssillä.

Viittaaminen

Consensus guidelines for the treatment of Nephrotic Syndrome in Children of Pakistan: Endorsed by Pakistan Pediatric Association- Nephrology Group. (2021). Pakistan Journal of Kidney Diseases, 3(8), 1-20. https://doi.org/10.53778/pjkd38101